BACKGROUND: As a result of improved surgical and therapeutical management, more than 90% of patients with congenital heart disease (CHD) reach adulthood. However, the natural course of CHD is complicated by noncardiac medical problems. Aim of the study was to evaluate noncardiac comorbidities in a contemporary cohort of adults with CHD (ACHD). METHODS: In a tertiary care center for ACHD, 821 consecutive patients, admitted to the outpatient clinic, were evaluated for clinically relevant noncardiac comorbidities. RESULTS: The consecutively included patients (age: range, 15-80 years; 56% female) represent all types and severity grades of acyanotic and cyanotic CHD. A considerable proportion of ACHD had significant noncardiac comorbidities, which have the potential to profoundly influence the natural course of the underlying disease. In 95.5%, relevant non-cardiac comorbidities were apparent, that could be related to 16 special medical fields as endocrinologic/metabolic disease, gastroenterology/hepatology, gynecology/obstetrics, angiology, orthopedics, neurology/psychiatry and others. Most frequently seen comorbidities were endocrine and metabolic disorders (43.97%). CONCLUSIONS: Non-cardiac comorbidities are increasingly common in ACHD. The data revealed non-cardiac comorbidities as they were presented in the cohort of ACHD seen in a tertiary center. The study proves that ACHD with significant non-cardiac comorbidities need multidisciplinary care by medical organ specialists, aside the congenital cardiologist, with a deep knowledge about congenital heart defects, the special effects of the organ disease on the particular heart defect and, how the heart defect may affect the course of the particular organ disease. The study may create the basis for the development of screening programs for comorbidities in ACHD as well as a multidisciplinary concept for diagnosis and treatment of concomitant disorders or for disease prevention. Particularly disease prevention may improve quality of life as well as the further fate of the affected patients.
BACKGROUND: As a result of improved surgical and therapeutical management, more than 90% of patients with congenital heart disease (CHD) reach adulthood. However, the natural course of CHD is complicated by noncardiac medical problems. Aim of the study was to evaluate noncardiac comorbidities in a contemporary cohort of adults with CHD (ACHD). METHODS: In a tertiary care center for ACHD, 821 consecutive patients, admitted to the outpatient clinic, were evaluated for clinically relevant noncardiac comorbidities. RESULTS: The consecutively included patients (age: range, 15-80 years; 56% female) represent all types and severity grades of acyanotic and cyanotic CHD. A considerable proportion of ACHD had significant noncardiac comorbidities, which have the potential to profoundly influence the natural course of the underlying disease. In 95.5%, relevant non-cardiac comorbidities were apparent, that could be related to 16 special medical fields as endocrinologic/metabolic disease, gastroenterology/hepatology, gynecology/obstetrics, angiology, orthopedics, neurology/psychiatry and others. Most frequently seen comorbidities were endocrine and metabolic disorders (43.97%). CONCLUSIONS: Non-cardiac comorbidities are increasingly common in ACHD. The data revealed non-cardiac comorbidities as they were presented in the cohort of ACHD seen in a tertiary center. The study proves that ACHD with significant non-cardiac comorbidities need multidisciplinary care by medical organ specialists, aside the congenital cardiologist, with a deep knowledge about congenital heart defects, the special effects of the organ disease on the particular heart defect and, how the heart defect may affect the course of the particular organ disease. The study may create the basis for the development of screening programs for comorbidities in ACHD as well as a multidisciplinary concept for diagnosis and treatment of concomitant disorders or for disease prevention. Particularly disease prevention may improve quality of life as well as the further fate of the affected patients.
Entities:
Keywords:
Congenital heart disease (CHD); adults; health care system; non-cardiac comorbidity; prevention
Authors: Rhoia Neidenbach; Harald Kaemmerer; Lars Pieper; Peter Ewert; Jörg Schelling Journal: Dtsch Med Wochenschr Date: 2017-02-24 Impact factor: 0.628
Authors: Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt Journal: Clin Res Cardiol Date: 2010-07-10 Impact factor: 5.460
Authors: A Hoffmann; P Chockalingam; O H Balint; A Dadashev; K Dimopoulos; R Engel; M Schmid; M Schwerzmann; M A Gatzoulis; B Mulder; E Oechslin Journal: Heart Date: 2010-08 Impact factor: 5.994
Authors: Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis Journal: Circulation Date: 2008-04-28 Impact factor: 29.690
Authors: H Kaemmerer; U Bauer; J-I Stein; S Lemp; D Bartmus; A Hoffmann; S Niesert; R Osmers; S Fratz; S Rossa; P E Lange; A Beitzke; K T M Schneider; J Hess Journal: Z Kardiol Date: 2003-01
Authors: Caroline Andonian; Jürgen Beckmann; Sabina Biber; Peter Ewert; Sebastian Freilinger; Harald Kaemmerer; Renate Oberhoffer; Lars Pieper; Rhoia Clara Neidenbach Journal: Cardiovasc Diagn Ther Date: 2018-12
Authors: Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer Journal: Cardiovasc Diagn Ther Date: 2018-12
Authors: Elvin Zengin; Christoph Sinning; Christopher Blaum; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch; Paulus Kirchhof; Nigel E Drury; Victoria M Stoll Journal: Cardiovasc Diagn Ther Date: 2021-04
Authors: Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk Journal: Cardiovasc Diagn Ther Date: 2021-04
Authors: Caroline Andonian; Fabian Langer; Jürgen Beckmann; Gert Bischoff; Peter Ewert; Sebastian Freilinger; Harald Kaemmerer; Renate Oberhoffer; Lars Pieper; Rhoia Clara Neidenbach Journal: Cardiovasc Diagn Ther Date: 2019-10
Authors: Julie De Backer; Lieven Annemans; Ruben Willems; Fouke Ombelet; Eva Goossens; Katya De Groote; Werner Budts; Stéphane Moniotte; Michèle de Hosson; Liesbet Van Bulck; Ariane Marelli; Philip Moons Journal: Eur J Health Econ Date: 2021-04-09
Authors: Rhoia Neidenbach; Stephan Achenbach; Caroline Andonian; Ulrike M M Bauer; Peter Ewert; Sebastian Freilinger; Ulrike Gundlach; Ann-Sophie Kaemmerer; Nicole Nagdyman; Kathrin Nebel; Renate Oberhoffer; Lars Pieper; Wibke Reinhard; Linda Sanftenberg; Fabian von Scheidt; Jörg Schelling; Lavinia Seidel; Michael Weyand; Harald Kaemmerer Journal: Cardiovasc Diagn Ther Date: 2021-04